Nohla Therapeutics

Provider of stem-cell transplants with umbilical cord blood as an alternative to bone-marrow transplants

placeSeattle, Washington, United States calendar_todayFounded 2015 groups48 employees language nohlatherapeutics.com

Registered entities

Investor mix

11 investors on record; lead investors include Arch Venture Partners, UTEC, Schroders Capital, Premier Partners.

Investor typeCountShare
Venture capital545%
Private equity19%
Other / undisclosed545%
Coming soon